Could combining anti-CD38 #antibodies improve MM treatment? This study shows #isatuximab & daratumumab bind non-competitively, with distinct apoptosis profiles. Pomalidomide enhances isatuximab-induced cell death!

👉 www.mdpi.com/1999-4923/17...
#MultipleMyeloma #CD38 #TargetedTherapy #Immunotherapy